D-0943-2017 Class III Terminated

Recalled by Sandoz Incorporated — Broomfield, CO

FDA drug recall D-0943-2017 was initiated by Sandoz Incorporated on Jun 16, 2017 and is designated Class III. Reason for recall: Cross Contamination With Other Product: Imipramine The recall status is terminated (terminated Jan 14, 2019). Affected quantity: 38,234 bottles.

Recall details

Product Type
Drugs
Report Date
Jul 12, 2017
Initiation Date
Jun 16, 2017
Termination Date
Jan 14, 2019
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
38,234 bottles

Product description

Amitriptyline HCl Tablets, USP 25 mg, Packaged in a)100-count bottles (NDC 0781-1487-01) and b) 1000-count bottles ( NDC 0781-1487-10), Rx only, Manufactured by Sandoz Inc., Princeton, NJ 08540

Reason for recall

Cross Contamination With Other Product: Imipramine

Distribution pattern

Product was distributed throughout the United States

Code information

Lot #: a) GR3831, GS9690, Exp. 08/2019; b) GR3832, Exp. 08/2019.

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0943-2017
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0943-2017. Report a data issue: hello@regdatalab.com.